Yen Zui-Shen, Chen Shyr-Chyr
Department of Emergency Medicine, Manchester Royal Infirmary, Oxford Road, Manchester M13 9WL, UK.
Emerg Med J. 2005 Sep;22(9):654-5. doi: 10.1136/emj.2005.028670.
A short cut review was carried out to establish whether the addition of nebulised furosemide to beta-agonist therapy improves outcomes in acute asthma. Altogether 87 papers were found using the reported search, of which two presented the best evidence to answer the clinical question. A further relevant paper was found on scanning the references of these papers. The author, date and country of origin, patient group studied, study type, relevant outcome, results, and study weaknesses of the best papers are tabulated. There is currently insufficient evidence to support the routine addition of nebulised furosemide to standard beta agonist therapy in acute asthma in adults.
进行了一项简短的循证综述，以确定在β受体激动剂治疗中添加雾化速尿是否能改善急性哮喘的治疗效果。通过报告的检索共找到87篇论文，其中两篇提供了回答该临床问题的最佳证据。在浏览这些论文的参考文献时又发现了一篇相关论文。表格列出了最佳论文的作者、日期、原产国、研究的患者群体、研究类型、相关结果、研究结果以及研究的不足之处。目前尚无足够证据支持在成人急性哮喘的标准β受体激动剂治疗中常规添加雾化速尿。
